The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sintilimab plus oxaliplatin and capecitabine versus sintilimab plus albumin-bound paclitaxel and capecitabine for advanced unresectable gastric and gastroesophageal junction (GEJ) adenocarcinoma patients: A prospective, randomized, open-label, investigator-initiated phase 2 trial.
 
Kai Chen
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Caihua Xu
No Relationships to Disclose
 
Qing Guo
No Relationships to Disclose
 
Dapeng Li
No Relationships to Disclose
 
Lian Lian
No Relationships to Disclose
 
Xiumin Zhou
No Relationships to Disclose
 
Yulan GU
No Relationships to Disclose
 
Wei Fu
No Relationships to Disclose
 
Weiming Duan
No Relationships to Disclose
 
Rong Wang
No Relationships to Disclose
 
Yonghua Zhang
No Relationships to Disclose